The global human microbiome market is witnessing a transformative phase, driven by rising awareness of gut health, advancements in microbiome-based therapeutics, and increasing investments in precision medicine. The market is projected to reach US$ 4.84 billion by 2031 , growing from US$ 1.07 billion in 2023 , at a robust CAGR of 20.8% during 2023–2031 . This remarkable expansion reflects...